Guardant Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the results of the Annual Meeting of Stockholders held on June 12, 2020. The filing details the outcomes of three proposals submitted to security holders for a vote.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following proposals were voted upon at the Annual Meeting:
- Proposal 1 (Election of Directors): All nominees listed in the Proxy Statement were elected.
- Ian Clark: 58,846,565 votes for; 17,200,048 votes withheld.
- Samir Kaul: 62,078,869 votes for; 13,967,744 votes withheld.
- Proposal 2 (Ratification of Auditors): The selection of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2020, was approved.
- Votes For: 84,018,801
- Votes Against: 58,471
- Abstentions: 18,967
- Proposal 3 (Say-on-Pay Frequency): Stockholders voted on an advisory basis for the frequency of future executive compensation votes. The majority voted for a one-year frequency.
- One Year: 75,681,736 votes
- Two Years: 31,914 votes
- Three Years: 273,197 votes
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the full list of elected directors and their tenure terms in the Definitive Proxy Statement (Schedule 14A) filed on April 28, 2020.
- Confirm the engagement letter terms with Ernst & Young LLP for the 2020 fiscal year.
- Note that the advisory vote on executive compensation frequency resulted in a mandate for annual votes (1-year cycle).
- Review the significant number of broker non-votes (8,049,626) recorded for the director elections.